AHA statement addresses CVD risk in NAFLDApril 14, 2022Lipid DisordersCAD & AtherosclerosisDiabetesMixed TopicsPreventive Care
High comorbidity rate seen before osteoarthritis diagnosisApril 13, 2022ThrombosisVenous ThromboembolismDiabetes
Empagliflozin rapidly improves acute heart failure symptoms in hospitalized patientsApril 13, 2022Heart FailureDiabetesInterventional Cardiology & SurgeryArrhythmias & EP
Novel tool could calculate CVD risk in T2DMApril 6, 2022HypertensionCAD & AtherosclerosisDiabetesLipid Disorders
New HF guidelines feature ‘quad’ therapy, tweaked terminologyApril 3, 2022Heart FailureHypertensionDiabetesInterventional Cardiology & SurgeryPreventive Care
SCORED: Sotagliflozin shows robust MACE benefitApril 2, 2022Acute Coronary SyndromesCAD & AtherosclerosisDiabetesStrokeHeart FailureLipid Disorders
Calcium scores predict sudden-death risk in preclinical CADMarch 30, 2022CAD & AtherosclerosisImagingLipid DisordersDiabetesHypertension
Be aware of gallbladder, biliary disease with newer obesity drugsMarch 30, 2022Lipid DisordersDiabetes
Hybrid ACC 2022 resurrects the live scientific sessionMarch 30, 2022Heart FailureAcute Coronary SyndromesArrhythmias & EPCAD & AtherosclerosisDiabetesHypertensionImaging
‘Profound implications’: COVID ups diabetes risk 40% a year laterMarch 23, 2022DiabetesCOVID-19 UpdatesLong COVID
